載入...
Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome
OBJECTIVE: Neonatal abstinence syndrome (NAS)—a clinical entity of infants from in utero exposure to psychoactive xenobiotic and buprenorphine—has been successfully used to treat NAS. However, nothing is known about the pharmacokinetics (PK) of buprenorphine in neonates with NAS. To our knowledge, t...
Na minha lista:
| 發表在: | Pharmacotherapy |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5119858/ https://ncbi.nlm.nih.gov/pubmed/26172282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1610 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|